KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 119 filers reported holding KURA ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,850,000 | +2.3% | 134,566 | +12.9% | 0.05% | +18.6% |
| Q3 2019 | $1,808,000 | -42.6% | 119,199 | -25.5% | 0.04% | -36.8% |
| Q2 2019 | $3,152,000 | +663.2% | 160,103 | +543.0% | 0.07% | +655.6% |
| Q1 2019 | $413,000 | -1.9% | 24,900 | +5.5% | 0.01% | +12.5% |
| Q2 2018 | $421,000 | -64.6% | 23,610 | -62.8% | 0.01% | -68.0% |
| Q1 2018 | $1,189,000 | +130.4% | 63,410 | +86.7% | 0.02% | +127.3% |
| Q4 2017 | $516,000 | +137.8% | 33,966 | +45.9% | 0.01% | +175.0% |
| Q2 2017 | $217,000 | – | 23,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |